*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Determination of MTHFR-G17793A gene polymorphism in Iraqi morbidly obese population and correlated that with apolipoprotein-A5 in increased risk of cardio vascular disease

Author: FATIMAH ABED, HANAAADDAI ALI, OMIDRANAEI SIADAT, SAREH ARJMAND, FATANEH FATEMI
Abstract: In this paper, because the methylenetetrahdrofolate reductase (MTHFR) association with many disease, we to evaluate the apolipoprotein-A5 (Apo-A5) levels and association of the polymorphism with morbidly obesity on risk of cardiovascular disease (CVD), a case-control study of 74 healthy morbidly obese and 76 healthy non-obese was conducted in Iraqi populationthat matched in gender and age. Apolipoprotein-A5, is main lipoprotein composing triglycerides rich lipoprotein and involving the risk of heart disease.Therefore Apo-A5 plays important role in regulation of lipids in the body. Although there are adequate traditional factors for cardiovascular risk but knowledge of genetic factor risk is still incomplete. Different biochemical parameters were measurement and polymorphism was genotyped by polymerase chain reaction (PCR-RFLP). The mean ± standard error (SE) and T test were estimate for clinical parameter and odds ratio (OR) with 95% confidence interval added to chi squire estimated for genotype to assess the strength of association between genetic and other factors. The results shows that morbidly obese have higher levels in blood pressure, cholesterol (Ch), triglyceride (TG), very low density lipoprotein (VLDL-C) and low density lipoprotein (LDL-C) than non-obese. In other hand shows not significant differences between two groups in value of high density lipoprotein (HDL-C) but show lower level in Apo-A5 in morbidly obese than non-obese groups. The study revealed that MTHFR-G1793A has not significant relation in three type normal homozygous ,heterozygous and rare homozygous with obesity.
Keyword: Apolipoprotein-A5, morbidly obese, MTHFR-G1793A, cardiovascular disease (CVD).
DOI: https://doi.org/10.31838/ijpr/2019.11.02.032
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free